8-KEarnings & ResultsExhibits & Filings

DEXCOM INC 8-K Report, Financial Results (Aug 6, 2014)

Filed August 6, 2014For Securities:DXCM

Summary

DexCom, Inc. (DXCM) filed an 8-K on August 6, 2014, primarily to furnish a press release detailing its financial results for the second quarter ended June 30, 2014. While the filing itself is procedural, the accompanying press release (Exhibit 99.01) is the crucial document for investors, containing the actual operational and financial performance data. Investors should carefully review this press release for details on revenue, profitability, and any forward-looking statements or business updates provided by the company.

Key Highlights

  • 1DexCom announced its financial results for the second quarter ended June 30, 2014, via a press release furnished with the 8-K filing.
  • 2The filing serves as a notification mechanism for the release of this quarterly financial information.
  • 3Exhibit 99.01 contains the full press release with detailed financial results and potentially other business updates.
  • 4Investors are directed to review Exhibit 99.01 for specific performance metrics and financial condition details.
  • 5This filing is furnished and not deemed 'filed' under Section 18 of the Securities Exchange Act of 1934, meaning it does not carry the same liabilities for inaccuracies unless fraud is involved.
  • 6Information provided is not automatically incorporated into other SEC filings unless explicitly stated.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report and furnish DexCom's financial results for the second quarter ended June 30, 2014, through an accompanying press release.

The detailed financial results and other relevant information for the quarter ended June 30, 2014, are contained within the press release furnished as Exhibit 99.01 to this 8-K filing.

While the 8-K filing itself does not contain these details, the accompanying press release (Exhibit 99.01) is likely to include forward-looking statements, business updates, and potentially financial guidance provided by DexCom's management.

When information is 'furnished' under Item 2.02, it is typically for disclosure purposes and is not subject to the same liability provisions under Section 18 of the Securities Exchange Act of 1934 as information that is formally 'filed'. However, it does not exempt the company from anti-fraud provisions.